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Abstract
Background: Studies have shown patients who are delayed for surgical cardiac revascularization
are faced with increased risks of symptom deterioration and death. This could explain the
observation that operative mortality among persons undergoing coronary artery bypass surgery
(CABG) is higher among women than men. However, in jurisdictions that employ priority wait lists
to manage access to elective cardiac surgery, there is little information on whether women wait
longer than men for CABG. It is therefore difficult to ascertain whether higher operative mortality
among women is due to biological differences or to delayed access to elective CABG.
Methods:  Using records from a population-based registry, we compared the wait-list time
between women and men in British Columbia (BC) between 1990 and 2000. We compared the
number of weeks from registration to surgery for equal proportions of women and men, after
adjusting for priority, comorbidity and age.
Results: In BC in the 1990s, 9,167 patients aged 40 years and over were registered on wait lists
for CABG and spent a total of 136,071 person-weeks waiting. At the time of registration for CABG,
women were more likely to have a comorbid condition than men. We found little evidence to
suggest that women waited longer than men for CABG after registration, after adjusting for
comorbidity and age, either overall or within three priority groups.
Conclusion: Our findings support the hypothesis that higher operative mortality during elective
CABG operations observed among women is not due to longer delays for the procedure.
Background
In publicly funded health care systems, priority wait lists
are commonly used to manage access to elective cardiac
surgery [1]. While queuing according to urgency of inter-
vention is designed to facilitate access to surgery within a
clinically appropriate time [2], patients who are delayed
for surgical cardiac revascularization are faced with
increased risks of worsening symptoms [3] and death
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[4,5]. The additional risks incurred by longer delays may
be of particular concern for women with cardiovascular
disease because, at presentation, women are more likely
than men to have comorbid medical conditions such as
hypertension, diabetes or obesity [6-11]. These comorbid
medical conditions may increase the amount of time that
women wait for CABG.
A number of studies have shown that the operative mor-
tality among women undergoing CABG surgery is higher
than that of men [12,13]. However, there is no informa-
tion on whether women wait longer than men for CABG,
after adjusting for age, severity of disease and comorbid-
ity. It is therefore difficult to ascertain whether higher
operative mortality may be due to delayed access to care
in the pre-surgical period. Addressing this question is
important for improving the care of persons with cardio-
vascular disease because, if differences are due to longer
waiting times, it might be feasible to implement strategies
to reduce waiting times among women.
The objective of this study was to compare the time from
registration on the wait list to CABG between women and
men, after adjusting for differences in age, severity of cor-
onary artery disease, and comorbidity. To examine the
consistency over time of any effects of sex on waiting
times, comparisons were done across synthetic cohorts of
patients defined by two-year periods of registration on the




The BC Cardiac Registries (BCCR) prospectively capture
the occurrence and timing of registration, surgery, or
removal from the wait lists without surgery, for all
patients accepted for cardiac surgery procedures in the
four heart-surgery centers delivering services in BC (popu-
lation of four million) [14]. Registered patients were
removed from the wait lists without surgery if they died,
declined the operation, accepted surgery from another
surgeon, moved away, or continued with medical man-
agement. Cardiac surgeons in BC have developed com-
mon guidelines for prioritizing patients and assigning the
suggested waiting time for surgery based on angina symp-
toms, affected coronary anatomy, non-invasive test
results, and left ventricular function impairment as
described elsewhere [15]. Using those guidelines, each
patient was classified by the surgeon into one of the fol-
lowing three groups: priority 1 if the suggested time to sur-
gery was three days, priority 2 if the suggested time to
Table 1: Characteristics of 9,167 patients registered for CABG surgery in British Columbia, 1991–2000
Women (N = 1,629) Men (N = 7,538)
Characteristic N (%) N (%)
Age Group (y)
40–49 68 (4.2) 600 (8.0)
50–59 241 (14.8) 1764 (23.4)
60–69 638 (39.2) 2892 (38.4)
70–79 633 (38.9) 2137 (28.3)
80–89 49 (3.0) 145 (1.9)
Urgency at Registration
Priority 1 123 (7.6) 534 (7.1)
Priority 2 1116 (68.5) 5339 (70.8)
Priority 3 377 (23.1) 1567 (20.8)
Unknown 13 (0.8) 98 (1.3)
Comorbidity at 
Registration
No comorbidity 750 (46.0) 3985 (52.9)
Major comorbidity (CHF, 
diabetes, COPD, 
rheumatism, cancer)
463 (28.4) 1540 (20.4)
Other conditions 416 (25.2) 2013 (26.7)
Registration Period
1991–1992 318 (19.5) 1394 (18.5)
1993–1994 297 (18.2) 1574 (20.9)
1995–1996 379 (23.3) 1619 (21.5)
1997–1998 350 (21.5) 1527 (20.3)
1999–2000 285 (17.5) 1424 (18.9)
Abbreviations: CABG = outpatient isolated coronary artery bypass surgery; CHF = congestive heart failure; COPD = chronic obstructive 
pulmonary diseaseBMC Cardiovascular Disorders 2007, 7:24 http://www.biomedcentral.com/1471-2261/7/24
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surgery was six weeks, and priority 3 if the suggested time
to surgery was 12 weeks.
Patients
There were 9,366 records of registration for isolated CABG
added to the Registry between January 1991 and Decem-
ber 2000. We excluded 135 records of patients who were:
emergency cases (30), removed on the registration date
(101), and had missing operating room reports (4). All
remaining 9,231 records had either the surgery date or the
date and reason of removal from the list without surgery.
We restricted the analyses to the first 52 weeks after regis-
tration so that 475 (5%) patients remaining on the lists at
12 months were censored. Of those, 167 eventually
underwent surgery; seven died; 78 received medical treat-
ment; 104 declined surgery; 17 were transferred to
another surgeon or hospital; and 102 were removed for
other reasons.
Comorbidity
To control for co-existing conditions, each patient was
classified as (1) presenting with no co-existing conditions,
(2) presenting with a major comorbid condition includ-
ing congestive heart failure, diabetes, chronic obstructive
pulmonary disease, cancer, or rheumatoid arthritis, or (3)
presenting with a minor comorbid condition including
other coexisting chronic conditions including peripheral
vascular disease, cerebrovascular disease, dementia, peptic
ulcer disease, hemiplegia, renal disease, or liver disease
[16]. The first set of conditions were those originally used
in a study on the appropriateness of coronary revasculari-
zation [17]. As we were concerned that there were other
potential concomitant illnesses that could delay surgery,
we added the other category that included conditions
from Charlson comorbidity index [18]. We entered two
indicator variables in the models to represent the three
comorbidity categories.
Statistical methods
Waiting times were analyzed as prospective observations
beginning at the time of registration. Each patient had a
waiting time calculated in calendar weeks from registra-
tion to surgery or removal for other reasons. The cumula-
tive probability of undergoing surgery as a function of
waiting time was estimated using the Kaplan-Meier
method [19]. Patients removed from the list for reasons
other than surgery were treated as censored observations.
Primary comparisons were done across synthetic cohorts
of patients defined by two-year periods of registration on
the wait lists. Within each registration period, differences
in the distributions of wait-list times between women and
men were examined using the log rank-test [20].
The effect size for each period was estimated using hazard
ratios for surgery derived from a Cox proportional hazards
model [21] in which we stratified on age. The priority
group and the comorbidity measures were included as
independent variables in the Cox model to estimate
adjusted effects. Hazard ratios (HR) for women evaluate
the conditional probability of undergoing CABG relative
to men at any week on the list. The weekly surgery rate was
calculated by dividing the number of operations by the
total number of patient-weeks on the list.
Table 2: Outcomes of registration for CABG surgery in British Columbia 1991–2000 at 52 weeks
Women (N = 1629) Men (N = 7538)
Outcomes N (%) N (%)
Underwent Surgery*
Within recommended time 534 (32.8) 2393 (31.7)
Beyond recommended 
time
845 (51.9) 4120 (54.7)
Between 1 and 12 weeks, 
priority unknown
8 (0.5) 33 (0.4)
Removed without 
surgery**
Died while waiting 9 (0.6) 81 (1.1)
Medical treatment 46 (2.8) 128 (1.7)
Patient request 42 (2.6) 145 (1.9)
Transferred or moved 12 (0.7) 87 (1.2)
Other reason 45 (2.8) 166 (2.2)
Still on wait list at 52 
weeks
88 (5.4) 385 (5.1)
Abbreviation: CABG = outpatient isolated coronary artery bypass surgery
* χ2 = 2.0, df = 2, p = 0.36
** χ2 = 14.8, df = 4, p = 0.0052BMC Cardiovascular Disorders 2007, 7:24 http://www.biomedcentral.com/1471-2261/7/24
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The Clinical Research Ethics Board of the University of
British Columbia approved the study protocol in Septem-
ber, 2001. Individual consent was waived.
Results and discussion
In BC in the 1990s, 9,167 patients aged 40 years and over
were registered on wait lists for CABG and spent a total of
136,071 person-weeks waiting. Of 9,167 persons aged 40
to 89 y who were registered for CABG in BC between 1991
and 2000, about 18% (1,629) were women (Table 1). At
registration for CABG, among women, 19% were under
age 60 y and 42% were over age 70 y, compared with 31%
of men under age 60 y and 30% over age 70 y. There was
a significant difference in the distribution of age between
women and men (X2 = 128.3, df = 4, P < 0.0001). The
number of women registered ranged from a low of 297 in
1993–1994 to a high of 379 in 1995–1996 (data not
shown).
At registration, 46% of women had no comorbid condi-
tions recorded, 25% had at least one minor comorbid
medical condition and 28% had at least one major
comorbid condition. Women were 20% less likely than
men to have no comorbid conditions (OR = 0.8) and 50%
more likely to have a major comorbid condition (OR =
1.5). There was a significant difference in the distribution
of comorbid medical conditions between women and
men (X2 = 51.9, df = 2, P < 0.0001). A similar proportion
of women and men received the operation within the rec-
ommended waiting time (Table 2).
Over all periods, at registration for CABG, approximately
equal proportions of women and men were in priority
group 1 (OR = 1.0, 95% CI: 0.8, 1.2 (adjusted for year and
age)), a lower proportion of women was in priority group
2 (OR = 0.9, 95% CI: 0.8, 1.0 (adjusted for year and age)),
and a higher proportion was in priority group 3 (OR = 1.2,
95% CI 1.0, 1.3 (adjusted for year and age)) (Table 3).
There was a significant difference in the distribution of
priority group among women and men (X2 = 7.72, df = 3,
P = 0.0521).
Among women, the distribution of priority group at regis-
tration for CABG remained approximately constant dur-
ing the first four periods; in the final period, there was a
reduced proportion in priority group 1 and an increased
proportion in the priority group 3. A similar pattern was
observed among men, with a relatively constant distribu-
tion of priority groups during the first four periods and a
shift in the last period to a reduced proportion in the most
urgent priority group and an increased proportion in the
least urgent priority group.
Among women and over all registration periods, the
median wait list time for outpatient isolated CABG in BC
was 11 weeks, ranging from 7 weeks in the earliest period
Table 3: Distribution of patients registered for CABG in British Columbia 1991–2000 by priority group and registration period
Priority 1 Priority 2 Priority 3
Registration 
Period
N( % )N( % )N( % )
Women
1991–1992 27 (8.5) 224 (70.4) 65 (20.4)
1993–1994 21 (7.1) 210 (70.7) 64 (21.5)
1995–1996 47 (12.4) 248 (65.4) 81 (21.4)
1997–1998 25 (7.1) 238 (68.0) 83 (23.7)
1999–2000 3 (1.1) 196 (68.8) 84 (29.5)
All periods* 123 (7.6) 1116 (68.5) 377 (23.1)
Men
1991–1992 88 (6.3) 990 (71.0) 267 (19.2)
1993–1994 89 (5.7) 1160 (73.7) 317 (20.1)
1995–1996 202 (12.5) 1105 (68.3) 291 (18.0)
1997–1998 91 (6.0) 1083 (70.9) 341 (22.3)
1999–2000 64 (4.5) 1001 (70.3) 351 (24.6)
All periods** 534 (7.1) 5339 (70.8) 1567 (20.8)
Abbreviation: CABG = outpatient isolated coronary artery bypass surgery
*Excludes 13 patients with unknown priority
**Excludes 98 patients with unknown priorityBMC Cardiovascular Disorders 2007, 7:24 http://www.biomedcentral.com/1471-2261/7/24
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to 16 weeks in the middle period (Table 4). Among men and over all registration periods, the median wait list time
was also 11 weeks, ranging from 9 weeks in the earliest
period to 14 weeks in the middle period. As measured by
the interquartile range (IQR), the variability in wait list
time over all periods was 1 week longer for women than
men (18 weeks versus 17 weeks).
One difference between women and men was observed
for those patients with longer waiting times: the wait-list
interval requiring 40% of operations in patients staying
on the lists longer than the median time was 6 weeks
longer among women than men, as measured by the dif-
ferences between 90th and 50th percentiles. The differential
between women and men reached a maximum 14 weeks
in 1993–1994.
The differences in time spent on the wait lists were not sig-
nificantly different between women and men in any cal-
endar period of registration (P > 0.10 for all periods). The
distributions of the estimated probability of undergoing
CABG at each week on the wait list for the period 1999–
2000 were overlapping for women and men over the first
36 weeks after registration (Figure 1).
For women, the average weekly rate of operations per 100
varied from 6.9 (6.1–7.7) in the 1991–1992 cohort to 4.7
(4.2–5.2) in the 1995–1996 cohort to 5.8 (5.1–6.6) in the
1999–2000 cohort (Table 5). At any week on the list, the
conditional probability of undergoing surgery was
Characteristics of 9,167 patients registered for outpatient  isolated coronary artery bypass surgery in British Columbia,  1991–2000 Figure 1
Characteristics of 9,167 patients registered for outpatient 
isolated coronary artery bypass surgery in British Columbia, 
1991–2000.

























































10th 25th 50th 75th 90th 90th – 50th
Women
1991–1992 1 2 7 19 43 36
1993–1994 1 4 8 18 49 41
1995–1996 1 6 16 27 53 37
1997–1998 3 6 15 26 40 25
1999–2000 3 6 11 19 47 36
A l l  p e r i o d s1 5 1 12 34 93 8
Men
1991–1992 1 3 9 19 44 25
1993–1994 2 4 9 18 44 25
1995–1996 1 6 14 26 46 32
1997–1998 2 6 13 24 43 30
1999–2000 3 6 10 19 39 29
A l l  p e r i o d s2 5 1 12 24 33 2
Abbreviation: CABG = outpatient isolated coronary artery bypass surgeryBMC Cardiovascular Disorders 2007, 7:24 http://www.biomedcentral.com/1471-2261/7/24
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reduced by 39% in 1995–1996 women, HR = 0.61 (0.51–
0.72), and by 13% in 1999–2000 women, HR = 0.87
(0.73–1.05), relative to the period 1991–1992, after
adjusting for priority, comorbidity, and age.
For men, the average weekly rate of operations per 100
varied from 6.5 (6.1–6.8) in the 1991–1992 cohort to 5.1
(4.9–5.4) in the 1995–1996 cohort to 6.3 (6.0–6.7) in the
1999–2000 cohort. At any week on the list, the condi-
tional probability of undergoing surgery was reduced by
28% in 1995–1996 men, HR = 0.72 (0.66–0.78), and by
7% in 1999–2000 men, HR = 0.93 (0.86–1.01), relative to
the period 1991–1992, after adjusting for priority, comor-
bidity, and age.
Within priority groups, there was little evidence that
women waited longer than men for CABG after registra-
tion, after adjusting for comorbidity, age and sex (Table
6).
Conclusion
In this paper we found little evidence that women waited
longer than men for elective CABG in BC during the
1990s. After adjusting for comorbidity and age, the time
spent on CABG wait lists did not differ between women
and men in any calendar period of registration or within
any of the three priority groups. A similar proportion of
women and men received the operation within the recom-
mended waiting time.
The distribution of women undergoing CABG was lower
than reported in other jurisdictions [6,8,22,23] and
within the range reported in other Canadian provinces: a
lower proportion (12%) of women was observed in Nova
Scotia [3] and a higher proportion (30%) in Alberta [24].
The significance of our findings can be understood within
the context that women have higher mortality after CABG
[6,25-28]. This issue was addressed using the United
States Society of Thoracic Surgeons National Cardiac Sur-
gery Database to examine peri-operative survival among
344,913 patients undergoing CABG between 1994 and
1997 [6]. After adjustment for other risk factors, female
sex remained an independent predictor of operative mor-
tality in all but very high risk patients. The main finding
in the current study – that waiting times did not differ
between women and men in BC – supports the hypothesis
that the higher operative mortality among women is due
to biological differences. Studies from the Cleveland
Clinic and the Northern New England Study Group have
shown the impact of body size on peri-operative CABG
mortality [29,30]. Women typically have a smaller body
surface area than men which in turn is associated with
smaller hearts and correspondingly diminutive coronary
arteries. This is thought to increase the technical difficulty
of CABG and contribute to poorer outcome [31]. Alterna-
tively, the differences in operative mortality may be due to
a delay in treatment or in referral to catheterization [32].
Other Canadian investigators found that the median





Total waiting time, 
weeks
Crude Rate, per 
100
SE RR 95% CI*
Women
1991–1992 281 4094.0 6.9 (0.4) 1.00 Referent
1993–1994 260 3892.5 6.7 (0.4) 0.98 (0.82, 1.17)
1995–1996 313 6676.5 4.7 (0.3) 0.61 (0.51, 0.72)
1997–1998 293 5587.5 5.2 (0.3) 0.68 (0.57, 0.81)
1999–2000 240 4103.5 5.8 (0.4) 0.87 (0.73, 1.05)
Men
1991–1992 1211 18773.0 6.5 (0.2) 1.00 Referent
1993–1994 1370 21221.0 6.5 (0.2) 1.01 (0.93, 1.09)
1995–1996 1403 27353.0 5.1 (0.1) 0.72 (0.66, 0.78)
1997–1998 1311 24570.0 5.3 (0.1) 0.79 (0.72, 0.85)
1999–2000 1251 19799.5 6.3 (0.2) 0.93 (0.86, 1.01)
Abbreviations: CABG = outpatient isolated coronary artery bypass surgery; SE = standard error; HR = hazard ratio; 95% CI = 95% confidence 
interval
*adjusted for priority group and comorbidity; stratified by age.
0 patients were on the wait list on December 31, 2001BMC Cardiovascular Disorders 2007, 7:24 http://www.biomedcentral.com/1471-2261/7/24
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duration between cardiac catheterization and surgery did
differ between women and men waiting for CABG or aor-
tic valve replacement in Nova Scotia [3].
We also found that, for one portion of the waiting time
distribution that included patients who waited longer
than the median waiting time as measured by the differ-
ences between 90th and 50th percentiles, the waiting time
was six weeks longer among women than men. An expla-
nation of this finding remains speculative and could serve
as the basis of a future study.
As reported by other investigators [6-11], we found that
women were significantly older and more likely to have a
major comorbid medical conditions when registered for
CABG. Part of this difference stems from women present-
ing with initial symptoms of cardiovascular disease at an
older age. This may also be indicative of differences in
health seeking behavior by women [33,34] or in referral
patterns from a cardiologist to a cardiac surgeon for
women with symptoms of cardiovascular disease [32].
Limitations
The internal validity of this study was high and it is
unlikely that potential biases could have materially
affected the results. Selection bias was minimized because
the registry maintains a record for virtually every person
assessed by a cardiac surgeon in BC and active follow-up
is undertaken for all persons registered. Information bias
was not a concern because there is no reason to believe
that any coding or other errors occurred differentially
among women and men. While there is always the possi-
bility of confounding in an observational study, the like-
lihood of a major unknown confounder is small because
it would need to have exerted a strong influence to sub-
stantially affecting the interpretation and results, and we
are unaware of any powerful factor that affected waiting
time.
The main question regarding the validity of the study is
the generalizability of the results. A study examining
whether the waiting time for CABG differs between
women and men in another jurisdiction that employs pri-
ority wait lists for CABG would be valuable. It would also
be of considerable interest to determine the impact of sex
in health systems that use wait lists but have different
types of reimbursement mechanisms.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
ARL conceived and designed the study, acquired the data,
interpreted the results, and drafted the manuscript. BGS
conceived and designed the study, analysed the data,
interpreted the results, and drafted the manuscript. LK
analysed the data and interpreted the results. RH partici-
pated in the design of the study, helped acquire the data,
and interpreted the results. SMM conceived and designed
the study and interpreted the results. All authors read and
approved the final manuscript.
Acknowledgements
The authors gratefully acknowledge the contributions of Rita Sobolyeva and 
Laurie Kilburn.
The following cardiac surgeons are contributors to the BCCR Surgical 
Research Committee: Drs. James Abel, Richard Brownlee, Larry Burr, 
Anson Cheung, James Dutton, Guy Fradet, Virginia Gudas, Robert Hayden, 
Eric Jamieson, Michael Janusz, Shahzad Karim, Tim Latham, Jacques LeBlanc, 
Sam Lichtenstein, Hilton Ling, John Ofiesh, Michael Perchinsky, Peter Skars-
gard and Frank Tyers.
This study received financial support from the: BC Research Institute of 
Women's and Children's Health, St Paul's Hospital Foundation (ARL), Van-
couver Coastal Health Research Institute (BGS, JMF), Michael Smith Foun-
dation for Health Research (ARL), Canada Foundation for Innovation (ARL, 
BGS), and Canada Research Chairs program (BGS).
References
1. Hurst J, Siciliani L: Tackling excessive waiting times for elective
surgery: a comparison of policies in twelve OECD countries.
Paris, Organisation for Economic Co-operation and Development;
2003. 
2. MacCormick AD, Collecutt WG, Parry BR: Prioritizing patients
for elective surgery: a systematic review.  ANZ J Surg 2003,
73:633-642.
3. Ray AA, Buth KJ, Sullivan JA, Johnstone DE, Hirsch GM: Waiting for
cardiac surgery: results of a risk-stratified queuing process.
Circulation 2001, 104:I92-I98.
4. Sobolev BG, Levy AR, Kuramoto L, Hayden R, Fitzgerald JM: Do
longer delays for coronary artery bypass surgery contribute
Table 6: Rate Ratios* by sex and priority group for patients undergoing CABG in British Columbia 1991–2000
Priority 1 Priority 2 Priority 3
Sex RR 95% CI RR 95% CI RR 95% CI
Men 1.00 Referent 1.00 Referent 1.00 Referent
Women 0.88 (0.69, 1.14) 0.99 (0.92, 1.06) 1.01 (0.88, 1.16)
Abbreviations: CABG = outpatient isolated coronary artery bypass surgery; RR = rate ratio; 95% CI = 95% confidence interval
*adjusted for comorbidity; stratified by age and registration periodPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cardiovascular Disorders 2007, 7:24 http://www.biomedcentral.com/1471-2261/7/24
Page 8 of 8
(page number not for citation purposes)
to preoperative mortality in less urgent patients?  Med Care
2006, 44:680-686.
5. Sobolev BG, Levy AR, Kuramoto L, Hayden R, Brophy JM, Fitzgerald
JM: The risk of death associated with delayed coronary artery
bypass surgery.  BMC Health Serv Res 2006, 6:85.
6. Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS: Impact of
gender on coronary bypass operative mortality.  Ann Thorac
Surg 1998, 66:125-131.
7. Hassan A, Chiasson M, Buth K, Hirsch GM: Women have worse
long-term outcomes after coronary artery bypass grafting
than men.  Canadian Journal of Cardiology 2005, 21:757-762.
8. Vaccarino V, Abramson JL, Veledar E, Weintraub WS: Sex differ-
ences in hospital mortality after coronary artery bypass sur-
gery - Evidence for a higher mortality in younger women.
Circulation 2002, 105:1176-1181.
9. Abramov D, Tamariz MG, Sever JY, Christakis GT, Bhatnagar G,
Heenan AL, Goldman BS, Fremes SE: The influence of gender on
the outcome of coronary artery bypass surgery.  Ann Thorac
Surg 2000, 70:800-805.
10. Koch CG, Weng YS, Zhou SX, Savino JS, Mathew JP, Hsu PH, Saidman
LJ, Mangano DT: Prevalence of risk factors, and not gender per
se, determines short- and long-term survival after coronary
artery bypass surgery.  Journal of Cardiothoracic and Vascular
Anesthesia 2003, 17:585-593.
11. Koch CG, Higgins TL, Capdeville M, Maryland P, Leventhal M, Starr
NJ: The risk of coronary artery surgery in women: A matched
comparison using preoperative severity of illness scoring.
Journal of Cardiothoracic and Vascular Anesthesia 1996, 10:839-843.
12. Jaglal SB, Tu JV, Naylor CD: Higher in-hospital mortality in
female patients following coronary artery bypass surgery: a
population-based study. Provincial Adult Cardiac Care Net-
work of Ontario.  Clin Invest Med 1995, 18:99-107.
13. Fisher LD, Kennedy JW, Davis KB, Maynard C, Fritz JK, Kaiser G,
Myers WO: Association of sex, physical size, and operative
mortality after coronary artery bypass in the Coronary
Artery Surgery Study (CASS).  J Thorac Cardiovasc Surg 1982,
84:334-341.
14. Volk T, Hahn L, Hayden R, Abel J, Puterman ML, Tyers GF: Reliabil-
ity audit of a regional cardiac surgery registry.  J Thorac Cardi-
ovasc Surg 1997, 114:903-910.
15. Levy AR, Sobolev BG, Hayden R, Kiely M, Fitzgerald JM, Schechter
MT: Time on wait lists for coronary bypass surgery in British
Columbia, Canada, 1991-2000.  BMC Health Serv Res 2005, 5:22.
16. Romano PS, Roos LL, Jollis JG: Adapting a clinical comorbidity
index for use with ICD-9-CM administrative data: differing
perspectives.  J Clin Epidemiol 1993, 46:1075-9; discussion 1081-9.
17. Naylor CD, Levinton CM, Baigrie RS: Adapting to waiting lists for
coronary revascularization. Do Canadian specialists agree
on which patients come first?  Chest 1992, 101:715-722.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of
classifying prognostic comorbidity in longitudinal studies:
development and validation.  J Chronic Dis 1987, 40:373-383.
19. Hosmer DW, Lemeshow S: .  In Applied Survival Analysis: regression
modeling time to event data New York, Wiley & Son; 1998:27-86. 
20. Klein JP, Moeschberger ML: Hypothesis testing.  In Survival analysis:
techniques for censored and truncated data New York, Springer;
1997:191-201. 
21. Cox DR: Regression models and life tables.  J R Stat Soc B 1972,
34:387-404.
22. Ayanian JZ, Epstein AM: Differences in the use of procedures
between women and men hospitalized for coronary heart
disease.  N Engl J Med 1991, 325:221-225.
23. Haglund B, Koster M, Nilsson T, Rosen M: Inequality in access to
coronary revascularization in Sweden.  Scand Cardiovasc J 2004,
38:334-339.
24. Ghali WA, Faris PD, Galbraith PD, Norris CM, Curtis MJ, Saunders
LD, Dzavik V, Mitchell LB, Knudtson ML: Sex differences in access
to coronary revascularization after cardiac catheterization:
importance of detailed clinical data.  Ann Intern Med 2002,
136:723-732.
25. Edwards FH, Ferraris VA, Shahian DM, Peterson E, Furnary AP, Haan
CK, Bridges CR: Gender-specific practice guidelines for coro-
nary artery bypass surgery: Perioperative management.  Ann
Thorac Surg 2005, 79:2189-2194.
26. Hammar N, Sandberg E, Larsen FF, Ivert T: Comparison of early
and late mortality in men and women after isolated coro-
nary artery bypass graft surgery in Stockholm, Sweden, 1980
to 1989.  J Am Coll Cardiol 1997, 29:659-664.
27. Carey JS, Cukingnan RA, Singer LKM: Health-Status After Myo-
cardial Revascularization - Inferior Results in Women.  Ann
Thorac Surg 1995, 59:112-117.
28. Edwards FH, Clark RE, Schwartz M: Coronary-Artery Bypass-
Grafting - the Society-Of-Thoracic-Surgeons National Data-
base Experience.  Ann Thorac Surg 1994, 57:12-19.
29. Loop FD, Golding LR, MacMillan JP, Cosgrove DM, Lytle BW, Sheldon
WC:  Coronary artery surgery in women compared with
men: analyses of risks and long-term results.  J Am Coll Cardiol
1983, 1:383-390.
30. O'Connor GT, Morton JR, Diehl MJ, Olmstead EM, Coffin LH, Levy
DG, Maloney CT, Plume SK, Nugent W, Malenka DJ, .: Differences
between men and women in hospital mortality associated
with coronary artery bypass graft surgery. The Northern
New England Cardiovascular Disease Study Group.  Circulation
1993, 88:2104-2110.
31. McLarty A, Mann N, Lawson WE, Foster A: Womens heart health
series: a mini-symposium.  Med Sci Monit 2003, 9:RA103-RA110.
32. Sheifer SE, Escarce JJ, Schulman KA: Race and sex differences in
the management of coronary artery disease.  Am Heart J 2000,
139:848-857.
33. Gibler WB, Armstrong PW, Ohman EM, Weaver WD, Stebbins AL,
Gore JM, Newby LK, Califf RM, Topol EJ: Persistence of delays in
presentation and treatment for patients with acute myocar-
dial infarction: The GUSTO-I and GUSTO-III experience.
Annals of Emergency Medicine 2002, 39:123-130.
34. Rosenfeld AG: Women's risk of decision delay in acute myo-
cardial infarction: Implications for research and practice.
AACN clinical issues 2001, 12:29-39.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2261/7/24/prepub